Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 19876 - 19900 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Cupric Chloride	Approved	VEGFA	7422	upregulated	cupric chloride results in increased expression of VEGFA mRNA	6p21.1	A21779
Cupric Chloride	Approved	ZNF12	7559	upregulated	cupric chloride results in increased expression of ZNF12 mRNA	7p22.1	A21778
Cupric oxide	Approved	ABCB10	23456	downregulated	cupric oxide results in decreased expression of ABCB10 mRNA	1q42.13	A21783
Cupric oxide	Approved	ACTR3B	57180	downregulated	cupric oxide results in decreased expression of ACTR3B mRNA	7q36.1-q36.2	A21783
Cupric oxide	Approved	AFF1	4299	upregulated	cupric oxide results in increased expression of AFF1 mRNA	4q21.3-q22.1	A21783
Cupric oxide	Approved	AJUBA	84962	downregulated	cupric oxide results in decreased expression of AJUBA mRNA	14q11.2	A21783
Cupric oxide	Approved	ALPK2	115701	downregulated	cupric oxide results in decreased expression of ALPK2 mRNA	18q21.31-q21.32	A21783
Cupric oxide	Approved	ALS2	57679	upregulated	cupric oxide results in increased expression of ALS2 mRNA	2q33.1	A21783
Cupric oxide	Approved	ANGPTL4	51129	downregulated	cupric oxide results in decreased expression of ANGPTL4 mRNA	19p13.2	A21783
Cupric oxide	Approved	ARC	23237	upregulated	cupric oxide results in increased expression of ARC mRNA	8q24.3	A21783
Cupric oxide	Approved	AREG	374	downregulated	cupric oxide results in decreased expression of AREG mRNA	4q13.3	A21783
Cupric oxide	Approved	ASNS	440	upregulated	cupric oxide results in increased expression of ASNS mRNA	7q21.3	A21783
Cupric oxide	Approved	ATF1	466	upregulated	cupric oxide results in increased expression of ATF1 mRNA	12q13.12	A21783
Cupric oxide	Approved	ATF3	467	upregulated	cupric oxide results in increased expression of ATF3 mRNA	1q32.3	A21783
Cupric oxide	Approved	ATP6V1A	523	upregulated	cupric oxide results in increased expression of ATP6V1A mRNA	3q13.31	A21783
Cupric oxide	Approved	ATP6V1B2	526	upregulated	cupric oxide results in increased expression of ATP6V1B2 mRNA	8p21.3	A21783
Cupric oxide	Approved	ATP6V1C1	528	upregulated	cupric oxide results in increased expression of ATP6V1C1 mRNA	8q22.3	A21783
Cupric oxide	Approved	ATP6V1D	51382	upregulated	cupric oxide results in increased expression of ATP6V1D mRNA	14q23.3	A21783
Cupric oxide	Approved	ATP6V1G1	9550	upregulated	cupric oxide results in increased expression of ATP6V1G1 mRNA	9q32	A21783
Cupric oxide	Approved	ATP6V1H	51606	upregulated	cupric oxide results in increased expression of ATP6V1H mRNA	8q11.23	A21783
Cupric oxide	Approved	ATP7A	538	upregulated	cupric oxide analog results in increased expression of ATP7A mRNA	Xq21.1	A21784
Cupric oxide	Approved	ATP7B	540	upregulated	cupric oxide analog results in increased expression of ATP7B mRNA	13q14.3	A21784
Cupric oxide	Approved	ATR	545	downregulated	cupric oxide results in decreased expression of ATR mRNA	3q23	A21783
Cupric oxide	Approved	ATRX	546	downregulated	cupric oxide results in decreased expression of ATRX mRNA	Xq21.1	A21783
Cupric oxide	Approved	AURKA	6790	downregulated	cupric oxide results in decreased expression of AURKA mRNA	20q13.2	A21783

Displaying entries 19876 - 19900 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability